IP Library › Assignment 014871/0808
Patent Assignment
Reel/Frame 014871/0808

Change of Name

Recorded: 2004-01-16 Pages: 6
Assignor
BIO-TECHNOLOGY GENERAL CORP.
Executed: 2003-06-23
Assignee
SAVIENT PHARMACEUTICALS, INC.
ONE TOWER CENTER BOULEVARD, 14TH FLOOR, EAST BRUNSWICK, NEW JERSEY, 08816
Covered Properties (46)
Method for Recovering a Purified Animal Growth Hormone or Analog Thereof from a Bacterial Cell
Patent: 4,831,120 →
Application: 06/752,441 →
Plasmids for Expression of Human Superoxide Dismutase (Sod) Analogs Containing Lambda Pl Promoter with Engineered Restriction Site for Substituting Ribosomal Binding Sites and Methods of Use Thereof
Patent: 5,143,836 →
Application: 07/194,424 →
Expression Vectors Containing Lambda Pl Promoter and T1T2 Rna Termination Sequence, Plasmids Containing the Vectors, Hosts Containing the Plasmids and Related Methods
Patent: 5,126,252 →
Application: 07/317,434 →
Method for Recovering a Purified Animal Growth Hormone or Polypeptide Analog Thereof from a Bacterial Cell
Patent: 4,997,916 →
Application: 07/320,320 →
Plasmids for Expression of Human Superoxide Dismutase (Sod) Analogs Containing Lambda Pl Promoter with Engineered Restriction Site for Substituting Ribosomal Binding Sites and Methods of Use Thereof
Patent: 5,162,217 →
Application: 07/449,125 →
Fibrin Binding Domain Polypeptide and Method of Producing
Patent: 5,270,030 →
Application: 07/526,397 →
Plasmids for the Production of Human Cu-Zn Superoxide Dismutase Bacterial Hosts Containing the Plasmids and Methods for Production and Recovery of Such Superoxide Dismutase
Patent: 5,112,744 →
Application: 07/539,367 →
Plasmids for Production of Met-Asp-Gln Bovine Growth Hormone, Hosts Containing the Plasmids, Products Manufactured Thereby and Related Methods
Patent: 5,198,361 →
Application: 07/635,413 →
Use of Intratracheal Administration of Sod to Protect Humans from Lung Injury Due to Hyperoxia and Hyperventilation
Patent: 5,116,616 →
Application: 07/692,630 →
Stabilized Expression Vectors Containing Lambda Pl Promoter and the Gene for the CI434 Repressor, Plasmids Containing the Vectors, Hosts Containing the Plasmids and Related Methods
Patent: 5,147,789 →
Application: 07/780,353 →
Method for Production and Purification of Hepatitis B Vaccine
Patent: 5,242,812 →
Application: 07/790,485 →
Expression Vectors Containing Lambdapl Promoter, T1T2 Rrna Termination Sequence, and Origin of Replication Derived from a Constitutive High Copy Number Plasmid and Hosts Containing the Plasmids
Patent: 5,151,364 →
Application: 07/822,054 →
Bacterial Expression of Porcine Growth Hormone
Patent: 5,256,546 →
Application: 07/840,579 →
Polypeptide Analogs of Human Manganese Superoxide Dismutase and Compositions and Complexes Thereof
Patent: 5,246,847 →
Application: 07/842,740 →
Plasmids for Expression and Method of Producing a Human Manganese Superoxide Dismutase Analog
Patent: 5,270,195 →
Application: 07/912,213 →
Detection, Correction and Display of Illegal Color Information in a Video Signal
Patent: 5,373,327 →
Application: 08/023,248 →
Method for Purification of Recombinant Copper/Zinc (Cu-Zn) Superoxide Dismutase from Bacteria or Eucaryotic Cells
Patent: 5,360,729 →
Application: 08/029,030 →
Fibrin Binding Domain Polypeptides and Uses and Methods of Producing Same
Patent: 5,455,158 →
Application: 08/058,241 →
Expression Plasmids Regulated by an Osmb Promoter
Patent: 5,795,776 →
Application: 08/216,851 →
Method for Ameliorating Muscle Weakness/Wasting in a Patient Infected with Human Immunodeficiency Virus-Type 1
Patent: 6,090,799 →
Application: 08/244,988 →
Fibrin Binding Domain Polypeptides and Uses and Methods of Producing Same
Patent: 5,679,320 →
Application: 08/259,569 →
Expression Plasmids Containing the Deo Promoter, and Bacterial Hosts Containing the Plasmids
Patent: 5,593,860 →
Application: 08/261,750 →
Human Manganese Superoxide Dismutase Dna, Its Expression and Method of Recovering Human Manganese Superoxide Dismutase
Patent: 6,610,520 →
Application: 08/299,047 →
Plasmids for Production of Human Growth Hormone or Polypeptide Analog Thereof, Hosts Containing the Plasmids, Products Manufactured Thereby, and Related Methods
Patent: 5,637,495 →
Application: 08/340,045 →
Contraception System and Method
Patent: 35,724 →
Application: 08/369,309 →
Methods of Use of Human Manganese Superoxide Dismutase
Patent: 5,540,911 →
Application: 08/370,461 →
Method of Removing N-Terminal Amino Acid Residues from Eucaryotic Polypeptide Analogs and Polypeptides Produced Thereby
Patent: 5,763,215 →
Application: 08/400,544 →
Fibrin Binding Domain Polypeptides and Uses and Methods of Producing Same
Patent: 5,965,383 →
Application: 08/409,750 →
Expression Vectors Containing Lambda Pl Promoter and T1 T2 Rrna Termination Sequence Plasmids Containing the Vectors Hosts Containing the Plasmids and Related Methods
Patent: 5,759,816 →
Application: 08/450,014 →
Plasmids for Expression of Human Superoxide Dismutase (Sod) Analogs Containing Lambda Pl Promoter with Engineered Restriction Site for Substituting Ribosomal Binding Sites, Sod Analogs, Methods of Recovery and Uses Thereof
Patent: 6,030,611 →
Application: 08/451,474 →
Bacterial Expression of Superoxide Dismutase
Patent: 5,670,371 →
Application: 08/459,356 →
Expression Plasmids Containing the Deo Promoter, and Bacterial Hosts Containing the Plasmids
Patent: 6,010,875 →
Application: 08/686,465 →
Human Manganese Superoxide Dismutase Dna, Its Expression and Method of Recovering Human Managanese Superoxide Dismutase
Patent: 6,361,772 →
Application: 08/686,466 →
Production of Enzymatically Active Recombinant Carboxypeptidase B
Patent: 5,948,668 →
Application: 08/782,760 →
Fibrin Binding Domain Polypeptides and Uses and Methods of Producing Same
Patent: 5,869,616 →
Application: 08/826,885 →
Expression Vectors for Enhanced Production of Polypeptides, Plasmids Containing the Vectors, Host Containing the Plasmids, Products Manufactured Thereby and Related Methods
Patent: 6,054,291 →
Application: 08/871,302 →
Expression Plasmids Regulated by an Osmb Promoter
Patent: 5,945,304 →
Application: 08/897,043 →
Fibrin Binding Domain Polypeptides and Uses and Methods of Producing Same
Patent: 6,121,426 →
Application: 08/909,140 →
Refolding of Proinsulins Without Addition of Reducing Agents
Patent: 6,001,604 →
Application: 08/967,867 →
Use of Oxandrolone in the Treatment of Burns and Other Wounds
Patent: 6,576,659 →
Application: 08/985,734 →
Use of Oxandrolone in the Treatment of Chronic Obstructive Pulmonary Disease
Patent: 5,872,147 →
Application: 08/986,015 →
Method for Ameliorating Muscle Weakness/Wasting in a Patient Infected with Human Immunodeficiency Virus-Type 1
Patent: 6,670,351 →
Application: 09/469,817 →
Fibrin Binding Domain Polypeptides and Uses and Methods of Producing Same
Patent: 7,087,722 →
Application: 09/492,971 →
Use of Oxandrolone in the Treatment of Burns and Other Wounds
Patent: 6,828,313 →
Application: 10/011,377 →
Publication: US 2002/0165266
Method for ameliorating muscle weakness/wasting in a patient infected with human immunodeficiency virus-type 1
Application: 10/052,961 →
Publication: US 2002/0091155
Syringe
Patent: 403,064 →
Application: 29/040,830 →
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignors Interest. Nov 5, 1984
From: LOCKER-GILADI HILLA; OPPENHEIM, AMOS B.; LEVANON, AVIGDOR; GORECKI, MARIAN
To: BIO-TECHNOLOGY GENERAL CORP.
Reel/Frame 004337/0234 →
Security Interest Oct 25, 1989
From: BIO-TECHNOLOGY GENERAL CORP.
To: CONTINENTAL STOCK TRANSFER AND TRUST COMPANY
Reel/Frame 005208/0641 →
Security Interest Oct 25, 1989
From: BIO-TECHNOLOGY GENERAL CORP.
To: CONTINENTAL STOCK TRANSFER AND TRUST COMPANY
Reel/Frame 005224/0821 →
Security Interest Oct 25, 1989
From: BIO-TECHNOLOGY GENERAL CORP., 1250 BROADWAY, NEW YORK, NY. 10001, A CORP. OF DE.; BIO-TECHNOLOGY GENERAL CORP., 1250 BROADWAY, NEW YORK, NY. 10001, A CORP. OF DE.
To: CONTINENTAL STOCK TRANSFER AND TRUST COMPANY
Reel/Frame 005208/0761 →
Security Interest Oct 25, 1989
From: BIO-TECHNOLOGY GENERAL CORP., A CORP. OF DE
To: CONTINENTAL STOCK TRANSFER AND TRUST COMPANY
Reel/Frame 005208/0682 →
Assignment of Assignors Interest. Nov 7, 1989
From: LIFSHITZ, RUTH; HADARY, DANY
To: BIO-TECHNOLOGY GENERAL CORP.
Reel/Frame 005174/0633 →
Assignment of Assignors Interest. Jul 23, 1990
From: VOGEL, TIKVA; LEVANON, AVIGDOR; WERBER, MOSHE; GUY, RACHEL
To: BIO-TECHNOLOGY GENERAL CORP.
Reel/Frame 005383/0507 →
Assignment of Assignors Interest. Jun 17, 1991
From: GONENNE, AMNON
To: BIO-TEWCHNOLOGY GENERL CORP., A CORP. OF DE
Reel/Frame 005739/0148 →
Assignment of Assignors Interest. Apr 27, 1993
From: MCGEE, DANIEL; KLEIN, MATTHEW
To: HEWLETT-PACKARD COMPANY
Reel/Frame 006508/0993 →
Assignment of Assignor's Interest Jun 20, 1994
From: BERGER, JOSEPH R.
To: BTG PHARMACEUTICALS CORP.
Reel/Frame 007697/0179 →
Assignment of Assignor's Interest Sep 14, 1994
From: FISCHER, MEIR
To: BIO-TECHNOLOGY GENERAL CORP.
Reel/Frame 007132/0655 →
Change of Name Jan 11, 1996
From: BTG ACQUISITION SUBSIDIARY, INC.
To: BTG PHARMACEUTICALS CORP.
Reel/Frame 007769/0073 →
Merger Jan 11, 1996
From: GYNEX PHARMACEUTICALS, INC.
To: BTG ACQUISITION SUBSIDIARY, INC.
Reel/Frame 007769/0067 →
Merger Dec 6, 1996
From: BTG PHARMACEUTICALS CORPORATION
To: BIO-TECHNOLOGY GENERAL CORP.
Reel/Frame 008262/0685 →
Merger & Change of Name Feb 14, 2000
From: BTG PHARMACEUTICALS CORP.
To: BIO-TECHNOLOGY GENERAL CORP.
Reel/Frame 010615/0799 →
Change of Name Jun 21, 2004
From: BIO-TECHNOLOGY GENERAL CORP.
To: SAVIENT PHARMACEUTICALS, INC.
Reel/Frame 014754/0469 →
Release of Security Interest Jul 1, 2005
From: CONTINENTAL STOCK TRANSFER AND TRUST COMPANY
To: SAVIENT PHARMACEUTICALS, INC. (FORMERLY KNOWN AS BIO-TECHNOLOGY GENERAL CORP.)
Reel/Frame 016460/0231 →
Release of Patent Collateral Assignment Jul 1, 2005
From: CONTINENTAL STOCK TRANSFER AND TRUST COMPANY
To: SAVIENT PHARMACEUTICALS, INC. (FORMERLY KNOWN AS BIO-TECHNOLOGY GENERAL CORP.)
Reel/Frame 016460/0241 →
Security Agreement Jun 12, 2012
From: SAVIENT PHARMACEUTICALS, INC.
To: MORGAN STANLEY SENIOR FUNDING INC.
Reel/Frame 028363/0040 →
Corrective Assignment to Correct the Receiving Party Previously Recorded on Reel 028363 Frame 0040. Assignor(S) Hereby Confirms the Security Agreement. Jul 23, 2013
From: SAVIENT PHARMACEUTICALS, INC.
To: U.S. NATIONAL BANK ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 030936/0072 →
Security Agreement Feb 21, 2014
From: CREALTA PHARMACEUTICALS LLC
To: JEFFERIES FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 032319/0077 →
Security Agreement Mar 4, 2014
From: CREALTA PHARMACEUTICALS LLC
To: FIFTH STREET FINANCE CORP., AS COLLATERAL AGENT
Reel/Frame 032384/0285 →
Release of Security Interest Aug 10, 2015
From: U.S. BANK NATIONAL ASSOCIATION
To: SAVIENT PHARMACEUTICAL, INC.
Reel/Frame 036317/0049 →
Release of Security Interest Aug 10, 2015
From: U.S. BANK NATIONAL ASSOCIATION
To: SAVIENT PHARMA HOLDINGS, INC.
Reel/Frame 036316/0906 →
Release of Security Interest Aug 11, 2015
From: FIFTH STREET FINANCE CORP.
To: CREALTA PHARMACEUTICALS LLC
Reel/Frame 036297/0163 →